On May 9, Mr. Zhang Jian, Vice Chairman of Hunan Provincial Political Consultative Conference and Chairman of the Provincial Federation of Industry and Commerce, visited our company for guidance and understanding of the development status, problems and existing needs of enterprises. Chairman Zhu Zhihong of Jiudian Pharmaceutical Company, Vice General Manager Yang, Vice President Xiao Stability of Pharmaceutical Research Institute, Minister Wang Qianzhi of Human Resources Department and Director Liu Xianghui of Planning Department accompanied Chairman Zhang and his delegation to visit the R&D Laboratory of our Pharmaceutical Research Institute. During the visits and talks, Chairman Zhang carefully looked, listened carefully, asked in detail, understood the development of enterprises in an all-round way, and intuitively felt a series of achievements of "R&D-driven development" of our company, as well as the strong momentum of vigorous development.

Minister Wang Qianzhi briefed Chairman Zhang in detail on the company's scientific research and innovation, excellent production, high-quality products and development planning. Jiudian Pharmaceutical Co., Ltd. has three wholly-owned subsidiaries and two production bases of Hongyang Pharmaceutical Co., Ltd., Pudao Pharmaceutical Co., Ltd. and Tongyukang Pharmaceutical Co., Ltd. in Hunan Province, forming the industrial layout of "one company, three gardens". Adhering to the product strategy of "high-tech, new products and patent drugs", we have a high-quality R&D team of more than 300 people with doctoral, master's and overseas talents as the core, equipped with nearly 10,000 square meters of modern R&D laboratories, formed a complete experimental platform from small-scale test to pilot-scale production, and undertook post-doctoral research. Research station, new gel paste Hunan Engineering Technology Research Center, Hunan Respiratory Medicine Engineering Technology Research Center "one stop, two centers" function. The production base covers an area of nearly 140,000 square meters, and has more than 20 production lines that meet the new national GMP standards. The perfect quality control system has been officially certified by FDA of the United States, KFDA of Korea and other countries. After years of precipitation, the company has formed a product layout with high-end APIs as the leader, raw materials and excipients as well as preparations, chemical drugs and traditional Chinese medicine flying in tandem, and new special drugs combined with general drugs.

Zhu expressed his gratitude to the provincial and municipal governments at all levels and the Provincial Federation of industry and Commerce for their help and support to private enterprises such as Jiudian Pharmaceutical Company for many years. He also pointed out that the pharmaceutical industry was deeply influenced by the national policies, especially the policy of consistency evaluation and "4+7" purchasing with quantity in recent years. He hoped that the Provincial Committee and the provincial government would make great changes in the industry. The formulation of policies can fully consider the actual development of Hunan's pharmaceutical industry and help Hunan pharmaceutical enterprises stand out during the period of great changes in the industry. In addition, Zhu Dong also raised the hope that the government could further improve the enterprise policy support system, encourage and guide enterprises to carry out scientific research and innovation, and promote the high-quality development of Hunan pharmaceutical industry.

Chairman Zhang had a detailed understanding of our business environment and the difficulties in the development of our company from the aspects of medical policy, talent introduction, tax reduction and fee reduction. He also recognized that our company attaches great importance to scientific research. He pointed out that only by constantly innovating and mastering core technology can enterprises lead the development of the industry. Jiudian Pharmaceutical Company should adhere to generic drugs as its leading role. Starting point, the combination of imitation and innovation, and the development strategy of innovation. He emphasized that the current pharmaceutical industry is in the stage of supply-side reform, with frequent policies, which is conducive to the long-term and stable development of the industry as a whole and the emergence of high-quality pharmaceutical enterprises. In the process of reform, enterprises need to be hard to beat iron. Jiudian Pharmaceutical Company, as a listed company, should also use General Secretary Xi Jinping's "science and technology is the key factor". Guided by the idea that innovation is the soul of national progress, the foundation of a strong country, and driven by scientific and technological innovation in the future development, we should "grasp the core technology in our own hands" and make greater contributions to the construction of a healthy China.